3-(5-methoxy-2-methyl-1h-indol-3-yl)-1-(4-pyridinyl)-2-propen-1-one and Glioblastoma

Methuosis is a form of nonapoptotic cell death characterized by an accumulation of macropinosome-derived vacuoles with eventual loss of membrane integrity. Small molecules inducing methuosis could offer significant advantages compared to more traditional anticancer drug therapies that typically rely on apoptosis. Herein we further define the effects of chemical substitutions at the 2- and 5-indolyl positions on our lead compound 3-(5-methoxy-2-methyl-1H-indol-3-yl)-1-(4-pyridinyl)-2-propene-1-one (MOMIPP). We have identified a number of compounds that induce methuosis at similar potencies, including an interesting analogue having a hydroxypropyl substituent at the 2-position. In addition, we have discovered that certain substitutions on the 2-indolyl position redirect the mode of cytotoxicity from methuosis to microtubule disruption. This switch in activity is associated with an increase in potency as large as 2 orders of magnitude. These compounds appear to represent a new class of potent microtubule-active anticancer agents.

Topics: Alkenes; Antineoplastic Agents; Cell Cycle; Cell Death; Cell Proliferation; Glioblastoma; Humans; Indoles; Microscopy, Fluorescence; Microtubules; Pyridines; Structure-Activity Relationship; Tubulin; Tumor Cells, Cultured